NYSE:CCM - Concord Medical Services Stock Price, News & Analysis

$2.49
+0.05 (+2.05 %)
(As of 09/19/2019 03:08 PM ET)
Today's Range
$2.49
Now: $2.49
$2.49
50-Day Range
$2.2750
MA: $2.53
$2.85
52-Week Range
$1.85
Now: $2.49
$3.84
Volume10 shs
Average Volume3,626 shs
Market Capitalization$107.97 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.19
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. Read More…

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone86-10-5903-6688

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$27.76 million
Book Value$1.86 per share

Profitability

Miscellaneous

Employees583
Market Cap$107.97 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CCM News and Ratings via Email

Sign-up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.


Concord Medical Services (NYSE:CCM) Frequently Asked Questions

What is Concord Medical Services' stock symbol?

Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Hldg Ltd (NYSE:CCM) issued its quarterly earnings results on Wednesday, August, 24th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.21 by $0.27. The firm earned $18.93 million during the quarter. View Concord Medical Services' Earnings History.

Has Concord Medical Services been receiving favorable news coverage?

Media stories about CCM stock have trended negative recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Concord Medical Services earned a coverage optimism score of -2.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Concord Medical Services.

Are investors shorting Concord Medical Services?

Concord Medical Services saw a drop in short interest in August. As of August 31st, there was short interest totalling 2,500 shares, a drop of 59.0% from the July 31st total of 6,100 shares. Based on an average daily trading volume, of 14,200 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the company's shares are short sold. View Concord Medical Services' Current Options Chain.

Who are some of Concord Medical Services' key competitors?

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Concord Medical Services investors own include Hi-Crush Partners (HCLP), The Carlyle Group (CG), Fibrocell Science (FCSC), Laurentian Bank of Canada (LB), Arbutus Biopharma (ABUS), CTI BioPharma (CTIC), Exelixis (EXEL), Immunomedics (IMMU), IntelliPharmaCeutics Intl (IPCI) and Novavax (NVAX).

Who are Concord Medical Services' key executives?

Concord Medical Services' management team includes the folowing people:
  • Dr. Jianyu Yang, Chairman & CEO (Age 48)
  • Mr. Yaw Kong Yap, CFO & Pres (Age 55)
  • Ms. Xiao Fu, Chief Operating Officer (Age 52)
  • Dr. Matthew D. Callister, Chief Medical Officer (Age 49)
  • Ms. Xun Liu, Financial Controller

Who are Concord Medical Services' major shareholders?

Concord Medical Services' stock is owned by a number of of retail and institutional investors. Top institutional investors include Prescott Group Capital Management L.L.C. (0.76%) and Renaissance Technologies LLC (0.55%).

Which major investors are selling Concord Medical Services stock?

CCM stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C..

Which major investors are buying Concord Medical Services stock?

CCM stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy shares of Concord Medical Services?

Shares of CCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Concord Medical Services' stock price today?

One share of CCM stock can currently be purchased for approximately $2.49.

How big of a company is Concord Medical Services?

Concord Medical Services has a market capitalization of $107.97 million and generates $27.76 million in revenue each year. The company earns $-34,160,000.00 in net income (profit) each year or ($1.20) on an earnings per share basis. Concord Medical Services employs 583 workers across the globe.View Additional Information About Concord Medical Services.

What is Concord Medical Services' official website?

The official website for Concord Medical Services is http://www.concordmedical.com/.

How can I contact Concord Medical Services?

Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected]


MarketBeat Community Rating for Concord Medical Services (NYSE CCM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  177 (Vote Underperform)
Total Votes:  347
MarketBeat's community ratings are surveys of what our community members think about Concord Medical Services and other stocks. Vote "Outperform" if you believe CCM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CCM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/19/2019 by MarketBeat.com Staff

Featured Article: Resistance Level

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel